Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Subjects and caregivers must provide written Informed Consent and be willing to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
- AD: Diagnostic evidence of probable AD consistent with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) and National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria met by the site Physician at the time of the Screening visit. This evidence must be fully documented in the participant's file prior to the Baseline Visit.
- For amnestic Mild Cognitive Impairment (MCI): A Clinical Dementia Rating (CDR) of 0.5 (with memory box score of at least 0.5) and a memory complaint that is objectively verified using a test of episodic memory: Delayed recall from one paragraph of the Wechsler Logical Memory scale (cutoff scores by education - maximum score of 25).
- Less than or equal to 8 for 16 or more years of education; Less than or equal to 4 for 8-15 years of education; Less than or equal to 2 for 0-7 years of education.
- Mini Mental State Exam (MMSE) score of 21-30
- Male and female subjects of non child-bearing potential (or using appropriate birth control measures) who are at least 50 years of age.
- In generally good health, in the opinion of the Principal Investigator (PI), based on medical history, Body Mass Index (BMI), physical examination, vital signs, 12-lead ECG, and laboratory values, including hematology and chemistry values.
- No known genetic AD causes for early onset memory impairment (e.g., presenilin mutation), participants from a family with known autosomal dominant AD associated with mutations in APP, PS1, or PS2 genes or strongly suspected, but not yet identified mutations in APP, PS1 or PS2 genes or Down's syndrome are not eligible to enroll. Individuals from families with late onset AD with 2 or more affected family members may participate.
Type II diabetic subjects may be included provided that their disease and serum glucose values are controlled and being actively managed, as assessed by the PI using a fasting blood sugar and/or HgbA1C (per the PI's medical judgment in consultation with the Sponsor).
- Rosen-Modified Hachinski Ischemia Score less than or equal to 4.
- Diagnosis or history of other possible cause for or significant contributor to
dementia, including but not limited to other neurodegenerative disorders (eg,
frontotemporal dementia, Lewy body disease, vascular dementia), vitamin B12 deficiency
(reflex Methylmalonic Acid (MMA) and folate if B12 is low), untreated thyroid disease,
syphilis, alcoholism, severe or recurrent head injury that is clinically relevant to
the disease under study, or onset of dementia following heart surgery or cardiac
arrest.
- Diagnosis or history of cerebrovascular disease (eg, stroke, transient ischemic
attack), severe carotid stenosis, cerebral hemorrhage, intracranial tumor,
subarachnoid hemorrhage, or subdural hematoma that could contribute to the subject's
current cognitive or functional status, impair ability to fully participate in the
trial or that may impact status during the one week study.
- Specific exclusionary brain MRI findings identified prior to study or at baseline as
determined by the investigator that could either contribute to the subject's current
cognitive or functional decline impair ability to fully participate in the trial or
that may impact status during the trial:
- History of cancer within the last year (except for cutaneous basal cell, squamous cell
cancer resolved by excision, colon polyp resolved by excision, or non-progressive
prostate cancer per investigator's judgment).
- History of clinically significant cardiovascular or renal events.
- Subjects with uncontrolled hypertension even with therapeutic intervention
- History of clinically significant (as determined by the PI in consultation with the
Sponsor) syncope, seizure, head trauma, or clinically significant unexplained loss of
consciousness within the last 5 years.
- A diagnosis of major depressive disorder or other psychiatric illness as the primary
diagnosis per the DSM-IV text revision (TR) criteria per the investigator's judgment.
- History of schizophrenia, bipolar disorder, or other severe mental illness.
- Known history of alcohol or drug abuse (as defined by the DSM-IV-TR) within 5 years
prior to dosing or a positive result regarding use of illicit drugs on the drug
screening test.
- History of clinically significant symptoms of pulmonary disease that requires
treatment (eg. asthma, COPD, or other chronic respiratory conditions).
- Known positive Human immunodeficiency virus (HIV) status.
- Unwilling or unable to comply with the Life Style guidelines described in this
protocol.
Exclusions Related to Medications or Procedures
- Treatment with an investigational drug within 30 days or 5 half-lives (whichever is
longer) of Study Day 1.
- Use of tobacco- or nicotine-containing products within three months of study Day 1.
Use of medication(s) for cognitive enhancement ≤ 90 days before the first dose of study
medication.
- Prescription: including but not limited to donepezil, galantamine, rivastigmine,
tacrine, memantine, Axona™;
- Reason for stoppage of donepezil may not be related to tolerability issues or to gain
entry in this study.
- Non-prescription treatments for cognitive enhancement.
- Subjects with either non-removable ferromagnetic implants (such as cardiac
pacemaker), aneurysm clips or other foreign bodies that would contraindicate a
brain MRI scan.
- A clinically significant (as determined by the PI) abnormality in the 12-lead
ECG, including complete heart block, bradycardia (heart rate <40 beats/minute),
sinus pauses >2 seconds, second or third degree heart block, QTc >450 or other
abnormalities judged clinically significant by the PI.
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Birmingham, Alabama
- Goodyear, Arizona
- Phoenix, Arizona
- Phoenix, Arizona
- Sun City, Arizona
- Tucson, Arizona
- Tucson, Arizona
- Little Rock, Arkansas
- Berkeley, California
- Carson, California
- Costa Mesa, California
- Encino, California
- Fresno, California
- Fullerton, California
- Glendale, California
- Imperial, California
- La Jolla, California
- La Jolla, California
- Laguna Hills, California
- Long Beach, California
- Los Alamitos, California
- Los Angeles, California
- Los Angeles, California
- National City, California
- Newport Beach, California
- Oceanside, California
- Orange, California
- Pasadena, California
- Rancho Mirage, California
- Sacramento, California
- Sacramento, California
- San Diego, California
- San Diego, California
- San Francisco, California
- San Francisco, California
- Santa Ana, California
- Santa Monica, California
- Sherman Oaks, California
- Walnut Creek, California
- Boulder, Colorado
- Denver, Colorado
- Fort Collins, Colorado
- Danbury, Connecticut
- Fairfield, Connecticut
- New Haven, Connecticut
- New Haven, Connecticut
- Norwalk, Connecticut
- Waterbury, Connecticut
- Newark, Delaware
- Washington, District of Columbia
- Atlantis, Florida
- Bradenton, Florida
- Deerfield Beach, Florida
- Delray Beach, Florida
- Fort Lauderdale, Florida
- Fort Myers, Florida
- Fort Walton Beach, Florida
- Ft. Myers, Florida
- Hallandale Beach, Florida
- Hollywood, Florida
- Jacksonville, Florida
- Maitland, Florida
- Melbourne, Florida
- Miami, Florida
- Miami, Florida
- Miami, Florida
- Ocala, Florida
- Orange City, Florida
- Orlando, Florida
- Palm Beach Gardens, Florida
- Pembroke Pines, Florida
- Port Charlotte, Florida
- Sarasota, Florida
- South Miami, Florida
- St Petersburg, Florida
- St. Petersburg, Florida
- Tampa, Florida
- Tampa, Florida
- Tampa, Florida
- Tampa, Florida
- West Palm Beach, Florida
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Columbus, Georgia
- Decatur, Georgia
- Lawrenceville, Georgia
- Chicago, Illinois
- Chicago, Illinois
- Elk Grove Village, Illinois
- Peoria, Illinois
- Springfield, Illinois
- Elkhart, Indiana
- Fort Wayne, Indiana
- Indianapolis, Indiana
- Kansas City, Kansas
- Kansas City, Kansas
- Lenexa, Kansas
- Lexington, Kentucky
- Lexington, Kentucky
- Paducah, Kentucky
- Lake Charles, Louisiana
- New Orleans, Louisiana
- Shreveport, Louisiana
- Shreveport, Louisiana
- Scarborough, Maine
- Baltimore, Maryland
- Baltimore, Maryland
- Rockville, Maryland
- Belmont, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Haverhill, Massachusetts
- Newton, Massachusetts
- Pittsfield, Massachusetts
- Plymouth, Massachusetts
- Springfield, Massachusetts
- Springfield, Massachusetts
- Weymouth, Massachusetts
- Ann Arbor, Michigan
- Detroit, Michigan
- East Lansing, Michigan
- Grand Rapids, Michigan
- Kalamazoo, Michigan
- Rochester, Minnesota
- Flowood, Mississippi
- Hattiesburg, Mississippi
- Kansas City, Missouri
- Kansas City, Missouri
- St. Louis, Missouri
- St. Louis, Missouri
- Billings, Montana
- Great Falls, Montana
- Omaha, Nebraska
- Las Vegas, Nevada
- Dover, New Hampshire
- Lebanon, New Hampshire
- Berlin, New Jersey
- Eatontown, New Jersey
- Manchester, New Jersey
- Mount Arlington, New Jersey
- Princeton, New Jersey
- Stratford, New Jersey
- Toms River, New Jersey
- Albuquerque, New Mexico
- Albuquerque, New Mexico
- Albany, New York
- Albany, New York
- Albany, New York
- Brooklyn, New York
- Cedarhurst, New York
- Elmsford, New York
- Latham, New York
- Liverpool, New York
- New Hyde Park, New York
- New York, New York
- New York, New York
- New York, New York
- New York, New York
- Orangeburg, New York
- Rochester, New York
- Durham, North Carolina
- Hickory, North Carolina
- Hickory, North Carolina
- Raleigh, North Carolina
- Winston-Salem, North Carolina
- Beachwood, Ohio
- Canton, Ohio
- Canton, Ohio
- Cleveland, Ohio
- Columbus, Ohio
- Dayton, Ohio
- Toledo, Ohio
- Oklahoma City, Oklahoma
- Oklahoma City, Oklahoma
- Medford, Oregon
- Portland, Oregon
- Portland, Oregon
- Portland, Oregon
- Abington, Pennsylvania
- Allentown, Pennsylvania
- Jenkintown, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Pittsburgh, Pennsylvania
- Pittsburg, Pennsylvania
- East Providence, Rhode Island
- Providence, Rhode Island
- Providence, Rhode Island
- N. Charleston, South Carolina
- Sioux Falls, South Dakota
- Cordova, Tennessee
- Franklin, Tennessee
- Johnson City, Tennessee
- Knoxville, Tennessee
- Austin, Texas
- Dallas, Texas
- Dallas, Texas
- DeSoto, Texas
- Fort Worth, Texas
- Houston, Texas
- Houston, Texas
- San Antonio, Texas
- San Antonio, Texas
- Wichita Falls, Texas
- Salt Lake City, Utah
- Salt Lake City, Utah
- Bennington, Vermont
- Burlington, Vermont
- Alexandria, Virginia
- Charlottesville, Virginia
- Richmond, Virginia
- Seattle, Washington
- Seattle, Washington
- Wenatchee, Washington
- Madison, Wisconsin
- Milwaukee, Wisconsin
- Waukesha, Wisconsin
- Graz, Styria
- Wien, Vienna
- Calgary, Alberta
- Kamloops, British Columbia
- Kelowna, British Columbia
- Penticton, British Columbia
- Vancouver, British Columbia
- Kingston, Ontario
- London, Ontario
- London, Ontario
- Ottawa, Ontario
- Peterborough, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Whitby, Ontario
- Greenfield Park, Quebec
- Montreal, Quebec
- Montréal, Quebec
- Sherbrooke, Quebec
- Verdun, Quebec
- Tübingen, Baden-wuerttemberg
- Ulm, Baden-wuerttemberg
- Freiburg, Baden-Württemberg
- Günzburg, Bayern
- München, Bayern
- München, Bayern
- Regensburg, Byern
- Bochum, Nordrhein-westfalen
- Homburg/Saar, Saarland
- Leipzig, Sachen
- Dresden, Saschen
- Hamburg,
- Birmingham, Alabama
- Goodyear, Arizona
- Phoenix, Arizona
- Phoenix, Arizona
- Sun City, Arizona
- Tucson, Arizona
- Tucson, Arizona
- Little Rock, Arkansas
- Berkeley, California
- Carson, California
- Costa Mesa, California
- Encino, California
- Fresno, California
- Fullerton, California
- La Jolla, California
- La Jolla, California
- Laguna Hills, California
- Long Beach, California
- Los Alamitos, California
- Los Angeles, California
- Newport Beach, California
- Oceanside, California
- Orange, California
- Pasadena, California
- Sacramento, California
- Sacramento, California
- San Diego, California
- San Diego, California
- San Francisco, California
- San Francisco, California
- Santa Monica, California
- Sherman Oaks, California
- Walnut Creek, California
- Boulder, Colorado
- Denver, Colorado
- Fort Collins, Colorado
- Danbury, Connecticut
- Fairfield, Connecticut
- New Haven, Connecticut
- New Haven, Connecticut
- Norwalk, Connecticut
- Waterbury, Connecticut
- Newark, Delaware
- Washington, District of Columbia
- Atlantis, Florida
- Bradenton, Florida
- Deerfield Beach, Florida
- Delray Beach, Florida
- Fort Lauderdale, Florida
- Fort Myers, Florida
- Fort Myers, Florida
- Fort Walton Beach, Florida
- Hallandale Beach, Florida
- Jacksonville, Florida
- Maitland, Florida
- Melbourne, Florida
- Miami, Florida
- Miami, Florida
- Miami, Florida
- Miami, Florida
- Ocala, Florida
- Orlando, Florida
- Palm Beach Gardens, Florida
- Port Charlotte, Florida
- Saint Petersburg, Florida
- Sarasota, Florida
- Tampa, Florida
- Tampa, Florida
- Tampa, Florida
- Tampa, Florida
- West Palm Beach, Florida
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Columbus, Georgia
- Columbus, Georgia
- Decatur, Georgia
- Lawrenceville, Georgia
- Chicago, Illinois
- Elk Grove Village, Illinois
- Peoria, Illinois
- Springfield, Illinois
- Elkhart, Indiana
- Indianapolis, Indiana
- Kansas City, Kansas
- Lenexa, Kansas
- Lexington, Kentucky
- Lexington, Kentucky
- Paducah, Kentucky
- Lake Charles, Louisiana
- Shreveport, Louisiana
- Scarborough, Maine
- Rockville, Maryland
- Boston, Massachusetts
- Boston, Massachusetts
- Haverhill, Massachusetts
- Newton, Massachusetts
- Pittsfield, Massachusetts
- Plymouth, Massachusetts
- Springfield, Massachusetts
- Ann Arbor, Michigan
- Detroit, Michigan
- East Lansing, Michigan
- Kalamazoo, Michigan
- Rochester, Minnesota
- Hattiesburg, Mississippi
- Kansas City, Missouri
- Saint Louis, Missouri
- Saint Lous, Missouri
- Billings, Montana
- Great Falls, Montana
- Omaha, Nebraska
- Eatontown, New Jersey
- Manchester, New Jersey
- Princeton, New Jersey
- Toms River, New Jersey
- Albuquerque, New Mexico
- Albany, New York
- Albany, New York
- Albany, New York
- Elmsford, New York
- Latham, New York
- Liverpool, New York
- New Hyde Park, New York
- New York, New York
- New York, New York
- Orangeburg, New York
- Rochester, New York
- Durham, North Carolina
- Hickory, North Carolina
- Raleigh, North Carolina
- Canton, Ohio
- Columbus, Ohio
- Dayton, Ohio
- Oklahoma City, Oklahoma
- Oklahoma City, Oklahoma
- Medford, Oregon
- Portland, Oregon
- Portland, Oregon
- Portland, Oregon
- Abington, Pennsylvania
- Allentown, Pennsylvania
- Jenkintown, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Pittsburgh, Pennsylvania
- Pittsburgh, Pennsylvania
- East Providence, Rhode Island
- Providence, Rhode Island
- Providence, Rhode Island
- North Charleston, South Carolina
- Sioux Falls, South Dakota
- Cordova, Tennessee
- Johnson City, Tennessee
- Knoxville, Tennessee
- Nashville, Tennessee
- Austin, Texas
- Dallas, Texas
- Dallas, Texas
- DeSoto, Texas
- Fort Worth, Texas
- Houston, Texas
- San Antonio, Texas
- San Antonio, Texas
- Salt Lake City, Utah
- Salt Lake City, Utah
- Bennington, Vermont
- Burlington, Vermont
- Alexandria, Virginia
- Charlottesville, Virginia
- Richmond, Virginia
- Seattle, Washington
- Seattle, Washington
- Milwaukee, Wisconsin
- Waukesha, Wisconsin
- Graz, Styria
- Calgary, Alberta
- Kamloops, British Columbia
- Kelowna, British Columbia
- Kingston, Ontario
- London, Ontario
- Ottawa, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Whitby, Ontario
- Greenfield Park, Quebec
- Montréal, Quebec
- Montréal, Quebec
- Sherbrooke, Quebec
- Verdun, Quebec
- Providence, Rhode Island
- Sun City, Arizona
- Irvine, California
- Los Alamitos, California
- Northridge, California
- San Diego, California
- San Francisco, California
- New Haven, Connecticut
- Washington, District of Columbia
- Delray Beach, Florida
- Jacksonville, Florida
- Chicago, Illinois
- Indianapolis, Indiana
- Boston, Massachusetts
- Ann Arbor, Michigan
- Rochester, Minnesota
- Long Branch, New Jersey
- New York City, New York
- Rochester, New York
- Durham, North Carolina
- Portland, Oregon
- Pittsburgh, Pennsylvania
- Providence, Rhode Island
- Dallas, Texas
- Houston, Texas
- Bennington, Vermont
- Seattle, Washington
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease | |||
Official Title ICMJE | A Methodology Study To Evaluate The Acute Effects Of Donepezil On Regional Cerebral Perfusion And Cognition In Subjects With Amnestic MCI And Mild Alzheimer's Disease | |||
Brief Summary | The study hypothesizes that donepezil will have a positive impact on brain blood flow deficits in subjects with memory deficits and/or mild dementia and that improvements in brain blood flow will be accompanied by improvements in memory. | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Not Applicable | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Basic Science | |||
Condition ICMJE | Alzheimer's Disease | |||
Intervention ICMJE |
| |||
Study Arms ICMJE |
| |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Terminated | |||
Actual Enrollment ICMJE | 18 | |||
Original Estimated Enrollment ICMJE | 32 | |||
Actual Study Completion Date ICMJE | July 2012 | |||
Actual Primary Completion Date | July 2012 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Type II diabetic subjects may be included provided that their disease and serum glucose values are controlled and being actively managed, as assessed by the PI using a fasting blood sugar and/or HgbA1C (per the PI's medical judgment in consultation with the Sponsor).
Exclusion Criteria:
Exclusions Related to Medications or Procedures
Use of medication(s) for cognitive enhancement ? 90 days before the first dose of study medication.
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 50 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT01082965 | |||
Other Study ID Numbers ICMJE | A9001437 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Pfizer | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | July 2013 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |